Cryptogenic Organizing Pneumonia: A Case Report
Abstract
Cryptogenic organizing pneumonia (COP) is an idiopathic interstitial lung disease affecting the distal airways, characterized by the development of granulation tissue that obstructs the bronchioles and alveoli, leading to respiratory failure. This case report describes a 63-year-old female patient with a history of diabetes, hypertension, and hypothyroidism who presented with persistent productive cough and dyspnea, initially treated as community-acquired pneumonia. Despite empirical antibiotic therapy, the patient's symptoms persisted. Further investigation, including high-resolution CT (HRCT) scans and a CT-guided lung biopsy, revealed fibrotic exudates, interstitial fibrosis with inflammatory infiltrates, and epithelioid granuloma. A diagnosis of COP was made after multidisciplinary discussion, and corticosteroid therapy was initiated, leading to significant clinical improvement and resolution on repeat imaging. This case highlights the importance of considering COP in patients with nonresolving pneumonia and underlines the efficacy of corticosteroids in its management. It also emphasizes the need for a multidisciplinary approach combining clinical, radiological, and histological assessments to reach a definitive diagnosis. Early recognition and appropriate treatment are crucial in preventing complications such as fibrosis and respiratory failure.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.